Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Spectroscopic study of the interaction of U(VI) with transferrin and albumin for speciation of U(VI) under blood serum conditions.
Montavon G, Apostolidis C, Bruchertseifer F, Repinc U, Morgenstern A. Montavon G, et al. J Inorg Biochem. 2009 Dec;103(12):1609-16. doi: 10.1016/j.jinorgbio.2009.08.010. Epub 2009 Sep 2. J Inorg Biochem. 2009. PMID: 19800129
Cross-sections of the reaction 232Th(p,3n)230Pa for production of 230U for targeted alpha therapy.
Morgenstern A, Apostolidis C, Bruchertseifer F, Capote R, Gouder T, Simonelli F, Sin M, Abbas K. Morgenstern A, et al. Appl Radiat Isot. 2008 Oct;66(10):1275-80. doi: 10.1016/j.apradiso.2008.02.066. Epub 2008 Feb 20. Appl Radiat Isot. 2008. PMID: 18374585
Production of 230U/226Th for targeted alpha therapy via proton irradiation of 231Pa.
Morgenstern A, Lebeda O, Stursa J, Bruchertseifer F, Capote R, McGinley J, Rasmussen G, Sin M, Zielinska B, Apostolidis C. Morgenstern A, et al. Anal Chem. 2008 Nov 15;80(22):8763-70. doi: 10.1021/ac801304c. Epub 2008 Oct 17. Anal Chem. 2008. PMID: 18925748
Investigation of para-sulfonatocalix[n]arenes [n = 6, 8] as potential chelates for (230)U.
Montavon G, Repinc U, Apostolidis C, Bruchertseifer F, Abbas K, Morgenstern A. Montavon G, et al. Dalton Trans. 2010 Feb 7;39(5):1366-74. doi: 10.1039/b918426k. Epub 2009 Dec 2. Dalton Trans. 2010. PMID: 20104364
Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer.
Cędrowska E, Pruszyński M, Gawęda W, Żuk M, Krysiński P, Bruchertseifer F, Morgenstern A, Karageorgou MA, Bouziotis P, Bilewicz A. Cędrowska E, et al. Among authors: bruchertseifer f. Molecules. 2020 Feb 25;25(5):1025. doi: 10.3390/molecules25051025. Molecules. 2020. PMID: 32106568 Free PMC article.
Supply and Clinical Application of Actinium-225 and Bismuth-213.
Morgenstern A, Apostolidis C, Bruchertseifer F. Morgenstern A, et al. Among authors: bruchertseifer f. Semin Nucl Med. 2020 Mar;50(2):119-123. doi: 10.1053/j.semnuclmed.2020.02.003. Epub 2020 Feb 21. Semin Nucl Med. 2020. PMID: 32172796 Free PMC article. Review.
225Ac- and 213Bi-Substance P Analogues for Glioma Therapy.
Królicki L, Kunikowska J, Bruchertseifer F, Koziara H, Królicki B, Jakuciński M, Pawlak D, Rola R, Morgenstern A, Rosiak E, Merlo A. Królicki L, et al. Among authors: bruchertseifer f. Semin Nucl Med. 2020 Mar;50(2):141-151. doi: 10.1053/j.semnuclmed.2019.11.004. Semin Nucl Med. 2020. PMID: 32172799 Free article. Review.
Preclinical Targeted α- and β--Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies.
Puttemans J, Dekempeneer Y, Eersels JL, Hanssens H, Debie P, Keyaerts M, Windhorst AD, van der Aa F, Lecocq Q, Breckpot K, Morgenstern A, Bruchertseifer F, Lahoutte T, Devoogdt N, D'Huyvetter M. Puttemans J, et al. Among authors: bruchertseifer f. Cancers (Basel). 2020 Apr 21;12(4):1017. doi: 10.3390/cancers12041017. Cancers (Basel). 2020. PMID: 32326199 Free PMC article.
First patient exceeding 5-year complete remission after 225Ac-PSMA-TAT.
Rathke H, Bruchertseifer F, Kratochwil C, Keller H, Giesel FL, Apostolidis C, Haberkorn U, Morgenstern A. Rathke H, et al. Among authors: bruchertseifer f. Eur J Nucl Med Mol Imaging. 2020 May 28. doi: 10.1007/s00259-020-04875-y. Online ahead of print. Eur J Nucl Med Mol Imaging. 2020. PMID: 32468252 No abstract available.
First-Generation Bispidine Chelators for 213 BiIII Radiopharmaceutical Applications.
Bruchertseifer F, Comba P, Martin B, Morgenstern A, Notni J, Starke M, Wadepohl H. Bruchertseifer F, et al. ChemMedChem. 2020 Jul 2. doi: 10.1002/cmdc.202000361. Online ahead of print. ChemMedChem. 2020. PMID: 32613737
117 results
Jump to page
Feedback